Question 1

What is the catalog number for SUCLA2 Peptide - N-terminal region?

Accepted Answer

The catalog number for SUCLA2 Peptide - N-terminal region is orb2007575.

Question 2

What sizes are available for SUCLA2 Peptide - N-terminal region?

Accepted Answer

SUCLA2 Peptide - N-terminal region is available in the following size(s): 100 µg.

Question 3

Is SUCLA2 Peptide - N-terminal region in stock?

Accepted Answer

SUCLA2 Peptide - N-terminal region is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is SUCLA2 Peptide - N-terminal region used for?

Accepted Answer

SUCLA2 Peptide - N-terminal region

Question 5

What temperature does this product ship at?

Accepted Answer

Shipping temperature is chosen based on the product’s stability needs, ranging from ambient to dry ice, and is indicated on the product page. Any related shipping fee is shown clearly in your quotation.

Question 6

What is the molecular weight of the target protein?

Accepted Answer

Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.

Question 7

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

SUCLA2 Peptide - N-terminal region

Product Specifications

Product Name Alternative

UniProt

Form

Storage Conditions

Notes

Applications Notes

Tested Applications

NCBI Accession Number

Preservative

AA Sequence

Frequently Asked Questions

Explore Other Products

VLDL Receptor (VLDLR) Human Gene Knockout Kit (CRISPR)

ASCC1 Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI6G5]

LIN7 (LIN7B) Goat Polyclonal Antibody

Dystrophin (DMD) (Marker of Duchenne and Becker Muscular Dystrophy) (DMD/3244), 0.2mg/mL

1-Benzyl-4-phenyl-4-piperidinecarboxylic Acid Hydrochloride

Glyceryl Tripalmitelaidate